Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of cancer treatment that causes numbness, pain, and balance issues in a patient's hands and feet. This study focuses on finding a non-drug approach to help cancer survivors manage these uncomfortable symptoms. The main purpose of this research is to evaluate whether combining Electroacupuncture(EA) with a exercise training program works better than using electroacupuncture alone. Electroacupuncture uses gentle electrical pulses through acupuncture needles to stimulate nerves, while the exercise program aims to improve a patient's balance, physical strength, and movement safety. Participants will be randomly assigned to receive either the combination therapy or electroacupuncture alone. The study involves scheduled hospital visits along with home-based practice guided by instructional videos. The researchers aim to evaluate the efficacy of combined EA and exercise training program on neurological symptoms and quality of life in CIPN patients across different CTCAE grades.
Age range
18 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Total Neuropathy Score-reduced (TNS-r)
Timeframe: Baseline (Week 0), Mid-intervention (Week 4), and Post-intervention (Week 8).
Mini-Balance Evaluation Systems Test (Mini-BESTest)
Timeframe: Baseline (Week 0), Mid-intervention (Week 4), and Post-intervention (Week 8).
Semmes-Weinstein Monofilaments
Timeframe: Baseline (Week 0), Mid-intervention (Week 4), and Post-intervention (Week 8).
Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity(FACT/GOG-NTX)
Timeframe: Baseline (Week 0), Mid-intervention (Week 4), and Post-intervention (Week 8).
European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30)
Timeframe: Baseline (Week 0), Mid-intervention (Week 4), and Post-intervention (Week 8).
World Health Organization Quality of Life-BREF (WHOQOL-BREF)
Timeframe: Baseline (Week 0), Mid-intervention (Week 4), and Post-intervention (Week 8).